Heparin Sodium Injection shortage
Heparin Sodium Injection is currently listed in shortage by the FDA. The FDA lists 8 affected products. The reported reason: Other. This page was last refreshed from FDA data on Sep 22, 2026.
Heparin sodium injection is currently in short supply, though all four manufacturers reporting the shortage still list some stock available. One additional maker, Baxter Healthcare, also lists supply, so the medicine has not disappeared from the market.
Don’t stop or change your therapy on your own — ask your pharmacist about other manufacturers (see options) and your prescriber about a long-term plan.
Do you take this drug? See the ‘What to do’ recommendation from Dr. Brian Staiger, PharmD →What’s in shortage — at a glance
These figures count only the manufacturers that reported this shortage to the FDA — not every company that makes Heparin Sodium Injection. Other makers that haven’t reported a problem are shown in the green card below.
Shortage timeline
-
Sep 17, 2026Currently in shortage8 of 8 products affected.
-
Sep 15, 2026FDA refreshed this shortage record2 products updated.
-
Sep 11, 2026FDA refreshed this shortage record2 products updated.
-
Sep 9, 2026FDA refreshed this shortage record2 products updated.
-
Nov 14, 2017First reported to the FDA8 products first listed.
Built from FDA posting and update dates. The end date FDA publishes is the posting/update date, not a true resolution date, so durations are approximate.
What exactly is on backorder — by manufacturer
Manufacturer: B. Braun Medical Inc. 📞 800-227-2862 2 NDCS click to expand
| Status | NDC / product | Strength / size | Availability | Related information | Reason |
|---|---|---|---|---|---|
| Current | Heparin Sodium 2,000 Units in Sodium Chloride 0.9% in Plastic Container, Injection, 200 [USP'U]/100 mL (NDC 0264-9872-00) | — | Limited Availability | Estimated recovery: TBD; Manufacturing delays | Other |
| Current | Heparin Sodium 1,000 Units In Sodium Chloride 0.9% In Plastic Container, Injection, 200 [USP'U]/100 mL (NDC 0264-9872-10) | — | Limited Availability | Estimated recovery: TBD; Manufacturing delays | Other |
Manufacturer: Baxter Healthcare 📞 888-229-0001 2 NDCS click to expand
| Status | NDC / product | Strength / size | Availability | Related information | Reason |
|---|---|---|---|---|---|
| Current | Heparin Sodium In Sodium Chloride, Injection, 200 [USP'U]/100 mL (NDC 0338-0433-04) | — | Available | — | — |
| Current | Heparin Sodium In Sodium Chloride, Injection, 200 [USP'U]/100 mL (NDC 0338-0431-03) | — | Available | — | — |
Manufacturer: Fresenius Kabi USA, LLC 📞 888-386-1300 2 NDCS click to expand
| Status | NDC / product | Strength / size | Availability | Related information | Reason |
|---|---|---|---|---|---|
| Current | Heparin Sodium, Injection, 200 [USP'U]/100 mL (NDC 63323-519-77) | — | Unavailable | Next release September 2026. Check wholesalers for inventory. | Other |
| Current | Heparin Sodium, Injection, 200 [USP'U]/100 mL (NDC 63323-519-10) | — | Available | Check wholesalers for inventory | — |
Manufacturer: Hospira, Inc., a Pfizer Company 📞 844-646-4398 2 NDCS click to expand
| Status | NDC / product | Strength / size | Availability | Related information | Reason |
|---|---|---|---|---|---|
| Current | Heparin Sodium, Injection, 2,000 Units/1,000 mL (2 Units/mL) (NDC 0409-2222-12) | — | Available | — | — |
| Current | Heparin Sodium, Injection, 1,000 Units/500 mL (2 Units/mL) (NDC 0409-1005-20) | — | Available | — | — |
These rows are manufacturer reports to the FDA for Heparin Sodium Injection — they do not necessarily cover every manufacturer that makes this drug. A company appears here only if it told the FDA it has a supply problem, so other makers may still have stock. That’s the basis for the Where else can I get Heparin Sodium Injection? options further down this page.
Why is Heparin Sodium Injection in shortage?
Heparin sodium injection is on the shortage list because of supply problems with a couple of specific products. Fresenius Kabi has one version of the 200 units/100 mL product (NDC 63323-519-77) that is currently unavailable, with the next expected release not until September 2026 — though they do still have another version of that same strength available, so it's worth checking with wholesalers. B. Braun Medical is also reporting limited availability on both of their 200 units/100 mL products (the 1,000-unit and 2,000-unit bag sizes), and that's due to manufacturing delays at their facility — with no firm recovery date yet.
It's worth knowing that this report only covers these specific manufacturers and package sizes. The FDA reason listed is broadly categorized as "Other," meaning neither Fresenius Kabi nor B. Braun shared a more detailed public explanation beyond the manufacturing delays noted for B. Braun.
Based on the manufacturer-reported reason(s) and notes on file with the FDA for Heparin Sodium Injection, summarized in plain English by HelloPharmacist. A drug can be short for more than one reason, and the FDA updates these as manufacturers report changes.
What should I do if I take Heparin Sodium Injection?
Heparin Sodium Injection is currently on the FDA shortage list. I want to reassure you at the outset: the overall supply risk here is low, and every strength on this record still has an available source.
To help you find the one you take: all three listed strengths — 200 units/100 mL, 1,000 units/500 mL, and 2,000 units/1,000 mL — still have at least one manufacturer reporting supply. Right now, no strength has zero available source. All four manufacturers on this record are still supplying. A few individual product codes are marked unavailable or limited, and one specific package is not expected to release again until September 2026, but other makers cover the same strength.
The reported reason is listed simply as "Other," with some manufacturing delays noted. Because supply is spread across several companies, this has stayed manageable even though it has lasted over a year.
Here is what I suggest:
- Do not stop, skip, or change your dose on your own. This medicine works best when taken exactly as prescribed.
- Ask your pharmacy to order your strength; they can check wholesalers and other manufacturers.
- The same medicine is also available from another maker (Baxter Healthcare), so your pharmacy may be able to source it, though it may not be in local stock.
- If your exact product cannot be found, ask your prescriber or pharmacist about options.
Manufacturer contact numbers are listed on this page for reference; pharmacies usually handle those calls. This is national, manufacturer-reported information and may not match your local pharmacy's actual stock.
- Don’t stop or change the medication on your own — talk to your prescriber first.
- If this is part of an ongoing or essential regimen (for example HIV treatment or prevention, seizure, heart, transplant, diabetes or mental-health medicines), do not skip or ration doses — contact your pharmacist or prescriber right away to arrange continued supply before you run out.
- Ask your pharmacy to check other manufacturers, strengths, package sizes, and nearby stores.
- Ask your prescriber whether a different strength, formulation, or the brand/generic version is appropriate.
Uses, dosing, side effects, prices, and the complete FDA label — written in plain English and pharmacist-reviewed.
Where else can I get Heparin Sodium Injection?
FDA shortages are manufacturer-reported — a company only shows up on the shortage list if it told the FDA it has a supply problem, so not every maker of Heparin Sodium Injection is necessarily short. Below we pull together the other still-marketed options that are not reported in shortage: the same medicine from manufacturers that haven’t reported a problem, and alternative dosage forms. These may still be out of stock at your pharmacy, and only your prescriber or pharmacist can decide what’s right for you.
Same medicine, other manufacturers (not reported short)
Same active ingredient, dosage form & route as the shortage (matched on the FDB HICL ingredient code), from makers that have not filed a shortage with the FDA:
| Product | Strength | Form / route | Manufacturer | NDC |
|---|---|---|---|---|
| Heparin Sodium In Sodium Chloride | HEPARIN SODIUM 200 [USP'U]/100mL | Injection, Solution · Intravenous | Baxter Healthcare Corporation | 00338-0424-18 |
Therapeutic equivalents & pricing 9 productsclick to expand
Orange Book–rated equivalents of the affected strengths / sizes, with the latest NADAC price (a federal retail-acquisition benchmark, not your copay) and an evidence-based availability label. Cheapest first.
| Product | Manufacturer | Package | NADAC $/unit | AB rating | Availability |
|---|---|---|---|---|---|
| Heparin Sodium in Sodium Chloride 200 [USP'U]/100mL | B. | 1000 ml | — | AP | FDA listed |
| Heparin Sodium in Sodium Chloride 200 [USP'U]/100mL | B. | 500 ml | — | AP | FDA listed |
| Heparin Sodium In Sodium Chloride 200 [USP'U]/100mL | Baxter | 1000 ml | — | AP | FDA listed |
| Heparin Sodium In Sodium Chloride 200 [USP'U]/100mL | Baxter | 1000 ml | — | AP | FDA listed |
| Heparin Sodium 200 [USP'U]/100mL | Hospira, | 12 pouches | — | AP | FDA listed |
| Heparin Sodium 200 [USP'U]/100mL | Fresenius | 1000 ml | — | AP | FDA listed |
| Heparin Sodium In Sodium Chloride 200 [USP'U]/100mL | Baxter | 500 ml | — | AP | FDA listed |
| Heparin Sodium 200 [USP'U]/100mL | Hospira, | 20 pouches | — | AP | FDA listed |
| Heparin Sodium In Sodium Chloride 200 [USP'U]/100mL | Baxter | 500 ml | — | AP | FDA listed |
Equivalents share the same ingredient, strength, dosage form and route; an AB rating means the FDA considers them substitutable. NADAC is a national retail-pharmacy acquisition benchmark from CMS — not what you pay. Availability is inferred from recent pricing, not a stock check.
Other drugs in the same treatment class
These are different medicines — not other versions of Heparin Sodium Injection — that fall in the same broad treatment class (heparin and related preparations) . They are not automatic substitutes: they can differ in how they work, dosing, effectiveness, side effects and what they’re approved to treat. Do not switch on your own. This list is for information only — ask your prescriber or pharmacist whether any of them is appropriate for you.
Identity & classification
Where does this data come from?
Other hematology shortages
Heparin Sodium Injection shortage FAQs
Is Heparin Sodium Injection in shortage?
Why is Heparin Sodium Injection in shortage?
Which products are affected?
When will Heparin Sodium Injection be available again?
Can I still get Heparin Sodium somewhere?
What should I do if I take Heparin Sodium Injection?
Still have a question about the Heparin Sodium Injection shortage?
Ask a pharmacist about this shortage →View Heparin Sodium Injection on the FDA drug-shortage database →
Where does this data come from?
/drug/shortages) — drug, manufacturer & contact, NDC/product, status, availability, reason, therapeutic category and posting/update dates. Current / To Be Discontinued = active; Resolved is kept for history. The Supply-Risk rating is assessed per active ingredient and adds the FDA NDC Directory (still-marketed manufacturers by ingredient & form); same-medicine and equivalent products use First Databank classification + CMS NADAC pricing; Medicaid use + most-affected states come from CMS Medicaid State Drug Utilization Data. Reference only — confirm current status with the manufacturer or FDA before acting on it.